INEGY 10 MG/10 MG TABLETS

Riik: Iisrael

keel: inglise

Allikas: Ministry of Health

Toimeaine:

EZETIMIBE 10 MG; SIMVASTATIN 10 MG

Saadav alates:

MERCK SHARP & DOHME ISRAEL LTD

ATC kood:

C10AA01

Ravimvorm:

TABLETS

Manustamisviis:

PER OS

Valmistatud:

MERCK SHARP & DOHME (ITALIA) S.P.A.

Terapeutiline rühm:

SIMVASTATIN

Näidustused:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH.Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Loa andmise kuupäev:

2012-04-01